All submissions screened by
We are member of
In VMOST JOSSH Research Articles and Reports, the Materials and Methods section is published online so that sufficient detail can be provided to allow replication of the study. Study design should be described in detail and reagent description should facilitate replication (for example source and purity should be specified, there should be evidence that antibodies have been validated, and cell lines should be authenticated). Statistics must also be comprehensively described as outlined below. VMOST JOSSH follows the principles and guidelines for reporting preclinical research available at http://www.nih.gov/about/reporting-preclinical-research.htm. Data must be available either in the main text or Supplementary Material, archived in an approved database (with accession number included in the acknowledgements) (see [data deposition] (data deposition#)). Any concerns about your ability to meet VMOST JOSSH's requirements must be disclosed and discussed with an editor.
Generally, authors should describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the results.
Authors should present results in complete and transparent fashion so that stated conclusions are backed by appropriate statistical evaluation and limitations of the study are frankly discussed.
Authors are encouraged to follow published standard reporting guidelines for the study discipline. A chart providing links to major biomedical research reporting guidelines is available at the [U.S. National Library of Medicine] (http://www.nlm.nih.gov/services/research_report_guide.html). Other guidelines may be found at the relevant society website, for example the American Chemical Society gives standards for the characterization of organic and inorganic molecular compounds http://pubs.acs.org/page/jacsat/submission/org_character.html.
Guidelines for Specific Types of Studies
Human subjects research: Informed consent must be obtained for studies on humans after the nature and possible consequences of the studies are explained. A statement that informed consent was obtained must also appear in the manuscript. All research on humans must have approval from the institutional IRB (Institutional Review Board) or an equivalent body. The editors reserve the right to request IRB documents associated with a particular paper.
A CONSORT Statement. [CONSORT] (http://www.consort-statement.org/consort-2010) includes recommendations, a checklist of items that should be included in a comprehensive report, and a participant flow diagram. The recommended checklist should be completed and provided at the time of manuscript submission. The recommended trial flow diagram may be presented as a figure (usually Fig. 1). Reports of randomized controlled trials that do not conform to the CONSORT guidelines may be returned to authors for revision prior to formal review.
Registration of clinical trials. Clinical trials should generally be registered in accordance with the criteria outlined by the [International Committee of Medical Journal Editors ] (http://www.icmje.org/), including the June 2007 update. Authors should provide the trial registration number in the Acknowledgements section and provide a link to the trial registration, to be cited as a reference.
Biomarker studies: Putative biomarkers must be evaluated with an independent validation set. Reports of unvalidated biomarkers will only be considered in the context of a clear experimental, mechanistic connection to disease or other unique contribution to understanding of disease or clinical practice. A statement should be included in all biomarker papers describing how overfitting (training models on large numbers of variables measured on small numbers of subjects) and other forms of bias were avoided. We strongly recommend all papers reporting potential new biomarkers be evaluated by an independent statistician before submission.
Modeling studies: Computational models should be validated either experimentally or through a dataset independent of the training set. All assumptions should be clearly stated with sources provided in the references and notes section. The code/algorithm used for the study must be included as a file in the Supplementary Materials to allow replication of the results by interested readers.
Animal studies: For all animal experimentation described in the manuscript, VMOST JOSSH requires that authors state in the Methods section their adherence to the [NIH Guide for the Care and Use of Laboratory Animals] (http://oacu.od.nih.gov/regs/guide/guide.pdf), or the equivalent.
Genetically modified animals. To avoid confounding effects of inbred strain background, littermate controls should generally be used, although exceptions may be allowed. Justification for other control animals should be included. Authors should fully describe the source of their animals and number of times backcrosses were performed.
Describing new taxa
Algal, Fungal, and Botanical Names: Since January 2012, electronic publication of algal, fungal, and botanical names has been a valid form of publication. Manuscripts containing new taxon names or other nomenclatural acts must follow the guidelines set by the International Code of Nomenclature for algae, fungi, and plants. Further helpful information by Sandra Knapp et al. is available here.
Authors describing new fungal taxa should register the names with a recognized repository, such as Mycobank, and request a unique digital identifier which should be included in the published article.
Zoological Names: Since January 2012, electronic publication of zoological names has been a valid form of publication if certain conditions are met. Manuscripts containing new taxon names or other nomenclatural acts must follow the guidelines set by the International Commission on Zoological Nomenclature. We require the new taxon name and the article it is published in to be registered with ZooBank. The unique identifier provided by ZooBank should be included in the published article. Authors will be able to update ZooBank with the final citation following publication. Further helpful information by Frank-T. Krell is available here.
Bacterial Names: In accordance with the International Code of Nomenclature of Prokaryotes (ICNP) effective publication of new prokaryotic names in electronic journals is possible. In order to comply with rules of the International Committee on Systematics of Prokaryotes (ICSP) for valid publication authors must submit a copy of the published article in its final form, together with certificates of deposition of the type strain (for unrestricted distribution), in at least two internationally recognized, publicly accessible culture collections located in different countries, to the International Journal of Systematic and Evolutionary Microbiology (IJSEM) editorial office. Following review by the List Editor, effectively published names that conform to all of the rules of the ICNP will appear on a subsequent Validation List, in the order received, thereby becoming validly published.
Virus Names: The proposal of new virus names must follow the guidelines established by the International Committee on Taxonomy of Viruses (ICTV) in the International Code of Virus Classification and Nomenclature. Proposals for new virus taxa should be forwarded to the relevant Study Group of the ICTV for consideration.
The VMOST Journal of Social Sciences and Humanities (VMOST JOSSH) is the official tri-annual scientific title in English of Vietnam Ministry of Science and Technology. The VMOST JOSSH aims to become an international journal that meets the standards of the world’s leading databases of scientific journals such as Scopus, Web of Science. This is the first issue of the VMOST JOSSH, published in April 2022.
Copyright © 2022 The VMOST Journal of Social Sciences and Humanities
Address: No.113 Tran Duy Hung, Trung Hoa ward, Cau Giay district, Hanoi, Vietnam
Tel: +84 2439 436 793 - Fax: +84 2439 436 794 - Email: email@example.com
License No.459/GP-BTTTT issued by the Ministry of Information and Communications on July 20, 2021;
License No.50/GP-BTTTT issued by the Ministry of Information and Communications on February 01, 2023
Editor in Chief: Dr. Nguyen Thi Huong Giang